Evolution of Drug Survival with Biological Agents and Apremilast Between 2012 and 2018 in Patients with Psoriasis from the PsoBioTeq Cohort.

Saved in:
Bibliographic Details
Title: Evolution of Drug Survival with Biological Agents and Apremilast Between 2012 and 2018 in Patients with Psoriasis from the PsoBioTeq Cohort.
Authors: BETTUZZI, Thomas1,2, BACHELEZ, Hervé3, BEYLOT-BARRY, Marie4, ARLÉGUI, Hugo5, PAUL, Carle6, VIGUIER, Manuelle7, MAHÉ, Emmanuel8, BENETON, Nathalie9, JULLIEN, Denis10, RICHARD, Marie-Aleth11, JOLY, Pascal12, TUBACH, Florence5, DUPUY, Alain13, SBIDIAN, Emilie1,2,14 emilie.sbidian@aphp.fr, CHOSIDOW, Olivier1,15
Source: Acta Dermato-Venereologica. 2022, Vol. 102, p1-7. 7p.
Database: Academic Search Ultimate
Description
ISSN:00015555
DOI:10.2340/actadv.v101.566